Skip to main content

Celera Offers Database to Israel - Newspaper Says

NEW YORK, Dec 1 - Celera has offered a subscription to its genome database to the Israeli government, the Israeli newspaper Ha’aretz reported Friday.

The company offered the database subscription to Yossi Cucik, the director general of the Israeli prime minister’s office, when he visited the United States in mid-November, the newspaper said.

The database will be made available to academic institutions and government offices in Israel, Cucik told Ha’aretz.

Cucik has arranged a meeting between Celera CEO Craig Venter and Israeli Prime Minister Ehud Barak. The newspaper implied that Venter intended to visit Israel in the near future. Celera was not immediately available for comment.

This report follows Celera’s October announcement that it had licensed its database to Israel's Weizmann Institute of Science. Typically, Celera charges academic and public-sector subscribers between $6,000 and $15,000 per scientist for access to its database .

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.